留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

高脂血症与乳腺癌

徐雅莉 曹希 孙强

徐雅莉, 曹希, 孙强. 高脂血症与乳腺癌[J]. 协和医学杂志, 2017, 8(1): 4-8. doi: 10.3969/j.issn.1674-9081.2017.01.002
引用本文: 徐雅莉, 曹希, 孙强. 高脂血症与乳腺癌[J]. 协和医学杂志, 2017, 8(1): 4-8. doi: 10.3969/j.issn.1674-9081.2017.01.002
Yali Xu, Xi Cao, Qiang Sun. Medical Journal of Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(1): 4-8. doi: 10.3969/j.issn.1674-9081.2017.01.002
Citation: Yali Xu, Xi Cao, Qiang Sun. Medical Journal of Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(1): 4-8. doi: 10.3969/j.issn.1674-9081.2017.01.002

高脂血症与乳腺癌

doi: 10.3969/j.issn.1674-9081.2017.01.002
详细信息
  • 中图分类号: R737.9

Medical Journal of Peking Union Medical College Hospital

  • [1] Petracci E, Decarli A, Schairer C, et al. Risk factor modification and projections of absolute breast cancer risk[J]. J Natl Cancer Inst, 2011, 103:1037-1048. doi:  10.1093/jnci/djr172
    [2] Sisti JS, Collins LC, Beck AH, et al. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies[J]. Int J Cancer, 2016, 138:2346-2356. doi:  10.1002/ijc.29968
    [3] Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk[J]. Lancet Oncol, 2002, 3:565-574. doi:  10.1016/S1470-2045(02)00849-5
    [4] Capasso I, Esposito E, Pentimalli F, et al. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience[J]. Cancer Biol Ther, 2010, 10:1240-1243. doi:  10.4161/cbt.10.12.13473
    [5] Hua X, Wu J, Goldstein JL, et al. Structure of the human gene encoding sterol regulatory element binding protein-1(SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13[J]. Genomics, 1995, 25:667-673. doi:  10.1016/0888-7543(95)80009-B
    [6] Zelcer N, Hong C, Boyadjian R, et al. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor[J]. Science, 2009, 325:100-104. doi:  10.1126/science.1168974
    [7] Zhang L, Reue K, Fong LG, et al. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis[J]. Arterioscler Thromb Vasc Biol, 2012, 32:2541-2546. doi:  10.1161/ATVBAHA.112.250571
    [8] Karuna R, Holleboom AG, Motazacker MM, et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism[J]. Atherosclerosis, 2011, 214:448-455. doi:  10.1016/j.atherosclerosis.2010.10.042
    [9] Vrieling A, Buck K, Kaaks R, et al. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis[J]. Breast Cancer Res Treat, 2010, 123:641-649. doi:  10.1007/s10549-010-1116-4
    [10] Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms[J]. Arch Physiol Biochem, 2008, 114:71-83. doi:  10.1080/13813450801954303
    [11] Gunter MJ, Xie X, Xue X, et al. Breast cancer risk in metabolically healthy but overweight postmenopausal women[J]. Cancer Res, 2015, 75:270-274. doi:  10.1158/0008-5472.CAN-14-2317
    [12] Hu J, La Vecchia C, de Groh M, et al. Dietary cholesterol intake and cancer[J]. Ann Oncol, 2012, 23:491-500. doi:  10.1093/annonc/mdr155
    [13] Ronco AL, De Stefani E, Stoll M. Hormonal and metabolic modulation through nutrition: towards a primary prevention of breast cancer[J]. Breast, 2010, 19:322-332. doi:  10.1016/j.breast.2010.05.005
    [14] Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity[J]. JAMA, 1999, 282:1523-529. doi:  10.1001/jama.282.16.1523
    [15] Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia[J]. Endocrinol Metab Clin North Am, 2003, 32:855-867. doi:  10.1016/S0889-8529(03)00073-2
    [16] Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholes terolemia and breast cancer pathophysiology[J]. Science, 2013, 342:1094-1098. doi:  10.1126/science.1241908
    [17] Pfefferle AD, Herschkowitz JI, Usary J, et al. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts[J]. Genome Biol, 2013, 14:R125. http://europepmc.org/abstract/med/24220145
    [18] Llaverias G, Danilo C, Mercier I, et al. Role of cholesterol in the development and progression of breast cancer[J]. Am J Pathol, 2011, 178:402-412. doi:  10.1016/j.ajpath.2010.11.005
    [19] Undela K, Srikanth V, Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies[J]. Breast Cancer Res Treat, 2012, 135:261-269. doi:  10.1007/s10549-012-2154-x
    [20] Danilo C, Frank PG. Cholesterol and breast cancer development[J]. Curr Opin Pharmacol, 2012, 12:677-682. doi:  10.1016/j.coph.2012.07.009
    [21] Printz C. Researchers find link between high cholesterol and breast cancer[J]. Cancer, 2014, 120:3429. doi:  10.1002/cncr.29110
    [22] Kitahara CM, Berrington de Gonzalez A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea[J]. J Clin Oncol, 2011, 29:1592-1598. doi:  10.1200/JCO.2010.31.5200
    [23] Allott EH, Hursting SD. Obesity and cancer: mechanistic insights from transdisciplinary studies[J]. Endocr Relat Cancer, 2015, 22:R365-R386. http://pubmedcentralcanada.ca/pmcc/articles/PMC4631382/
    [24] Bensinger SJ, Bradley MN, Joseph SB, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response[J]. Cell, 2008, 134:97-111. doi:  10.1016/j.cell.2008.04.052
    [25] Alikhani N, Ferguson RD, Novosyadlyy R, et al. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model[J]. Oncogene, 2013, 32:961-967. doi:  10.1038/onc.2012.113
    [26] DuSell CD, McDonnell DP. 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling[J]. Trends Pharmacol Sci, 2008, 29:510-514. doi:  10.1016/j.tips.2008.07.003
    [27] DuSell CD, Umetani M, Shaul PW, et al. 27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator[J]. Mol Endocrinol, 2008, 22:65-77. doi:  10.1210/me.2007-0383
    [28] Nelson ER, DuSell CD, Wang X, et al. The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors[J]. Endocrinology, 2011, 152:4691-4705. doi:  10.1210/en.2011-1298
    [29] Fu X, Menke JG, Chen Y, et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells[J]. J Biol Chem, 2001, 276:38378-38387. doi:  10.1074/jbc.M105805200
    [30] Corsini A, Maggi FM, Catapano AL. Pharmacology of competitive inhibitors of HMG-CoA reductase[J]. Pharmacol Res, 1995, 31:9-27. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=183c38925252fe17a9fe6de3cc8dc7a6
    [31] Vini R, Juberiya AM, Sreeja S. Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM, 27-hydroxycholesterol[J]. IUBMB Life, 2016, 68:116-121. doi:  10.1002/iub.1465
    [32] Hansson M, Ellis E, Hunt MC, et al. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages[J]. Biochim Biophys Acta, 2003, 1593:283-289. doi:  10.1016/S0167-4889(02)00398-1
    [33] Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression[J]. Semin Cancer Biol, 2008, 18:349-355. doi:  10.1016/j.semcancer.2008.03.004
    [34] Wu Q, Ishikawa T, Sirianni R, et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth[J]. Cell Rep, 2013, 5:637-645. doi:  10.1016/j.celrep.2013.10.006
    [35] Bahl M, Ennis M, Tannock IF, et al. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study[J]. Breast Cancer Res Treat, 2005, 94:135-144. doi:  10.1007/s10549-005-6654-9
    [36] Jiralerspong S, Kim ES, Dong W, et al. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients[J]. Ann Oncol, 2013, 24:2506-2514. doi:  10.1093/annonc/mdt224
    [37] Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study[J]. J Natl Cancer Inst, 2011, 103:1461-1468. doi:  10.1093/jnci/djr291
    [38] Kwan ML, Habel LA, Flick ED, et al. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors[J]. Breast Cancer Res Treat, 2008, 109:573-579. doi:  10.1007/s10549-007-9683-8
    [39] Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality[J]. N Engl J Med, 2012, 367:1792-1802. doi:  10.1056/NEJMoa1201735
    [40] Raccosta L, Fontana R, Maggioni D, et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils[J]. J Exp Med, 2013, 210:1711-1728. doi:  10.1084/jem.20130440
    [41] Kaiser J. Cholesterol forges link between obesity and breast cancer[J]. Science, 2013, 342:1028. doi:  10.1126/science.342.6162.1028
    [42] Laisupasin P, Thompat W, Sukarayodhin S, et al. Comparison of serum lipid profiles between normal controls and breast cancer patients[J]. J Lab Physicians, 2013, 5:38-41. doi:  10.4103/0974-2727.115934
    [43] Lee WR, Ishikawa T, Umetani M. The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol[J]. Clin Lipidol, 2014, 9:617-624. doi:  10.2217/clp.14.53
  • 加载中
计量
  • 文章访问数:  170
  • HTML全文浏览量:  12
  • PDF下载量:  234
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-04-17
  • 刊出日期:  2017-01-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!